Thursday, March 26, 2026 | 08:37 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 29 - Pfizer

Pfizer says it's communicating with President-elect Joe Biden's team

Castillo says Pfizer is 'communicating with both sides' during the transition

Pfizer says it's communicating with President-elect Joe Biden's team
Updated On : 19 Nov 2020 | 1:50 AM IST

Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

The success rate of the vaccine developed by U.S. firm Pfizer and Germany's BioNTech is the highest of any candidate in late-stage clinical trials so far, and experts said it was a significant achieve

Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
Updated On : 19 Nov 2020 | 1:50 AM IST

Pfizer ends vaccine trial with 95% success rate, to apply for approval soon

Pfizer and BioNTech said they plan to submit the data to other regulatory agencies around the world.

Pfizer ends vaccine trial with 95% success rate, to apply for approval soon
Updated On : 19 Nov 2020 | 1:11 AM IST

Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head

Even the front-runners among vaccine companies would take at least a few months to complete Phase-III trials and evaluate the efficacy and safety of individual vaccines

Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head
Updated On : 18 Nov 2020 | 10:54 PM IST

Pfizer, BioNTech plan regulatory filing as vaccine proves 95% effective

The companies said their vaccine protected people of all ages and ethnicities

Pfizer, BioNTech plan regulatory filing as vaccine proves 95% effective
Updated On : 18 Nov 2020 | 5:49 PM IST

World Coronavirus Dispatch: All of Switzerland's ICU beds are full

UK govt under lens for £17 bn Covid deals, new cases in Russia top 22,000 a day, six-day lockdown in South Australia, and other pandemic-related news across the globe

World Coronavirus Dispatch: All of Switzerland's ICU beds are full
Updated On : 18 Nov 2020 | 2:13 PM IST

Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate

Federal health officials met with Pfizer representatives on as Brazil seeks to secure vaccine supplies

Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate
Updated On : 18 Nov 2020 | 8:23 AM IST

Centre examining all possible storage facilities for Pfizer's Covid vaccine

The Union Health Ministry said that the central government is examining all possibilities to extend cold chain facilities in case Pfizer's Covid-19 vaccine needs to be procured

Centre examining all possible storage facilities for Pfizer's Covid vaccine
Updated On : 18 Nov 2020 | 6:33 AM IST

We didn't delay vaccine results until after US election, says Pfizer CEO

Last week, Pfizer and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis

We didn't delay vaccine results until after US election, says Pfizer CEO
Updated On : 18 Nov 2020 | 1:34 AM IST

Decoded: Why the Moderna Covid-19 vaccine holds promise over Pfizer's

The Pfizer vaccine (more than 90 per cent effective) must be stored at minus 20 degrees Celsius. Creating cold chains to deliver this to billions is impossible in any reasonable time

Decoded: Why the Moderna Covid-19 vaccine holds promise over Pfizer's
Updated On : 18 Nov 2020 | 6:10 AM IST

Aviation and hotel stocks soar sharply on coronavirus vaccine hope

Shares of firms in the sectors have outperformed Sensex in November

Aviation and hotel stocks soar sharply on coronavirus vaccine hope
Updated On : 17 Nov 2020 | 11:01 PM IST

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul
Updated On : 17 Nov 2020 | 10:50 PM IST

Pfizer, Moderna: How 2 firms sprinted ahead in the race for a Covid vaccine

Both companies have reported preliminary findings of more than 90% effectiveness - an unexpectedly high rate - raising hope for an end to the pandemic

Pfizer, Moderna: How 2 firms sprinted ahead in the race for a Covid vaccine
Updated On : 17 Nov 2020 | 10:43 PM IST

Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drug

Pfizer Inc alleged that the drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent

Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drug
Updated On : 17 Nov 2020 | 10:27 PM IST

World Coronavirus Dispatch: US stocks at new high over Moderna vaccine data

Hungary and Poland block EU stimulus package, Citi says successful vaccines will see dollar plummet, No virus protection for jailed elderly Taxes and other pandemic-related news across the globe

World Coronavirus Dispatch: US stocks at new high over Moderna vaccine data
Updated On : 17 Nov 2020 | 2:07 PM IST

Britain expects to roll out Pfizer's Covid-19 vaccine before Christmas

"We're working very closely with the company," health minister told BBC TV

Britain expects to roll out Pfizer's Covid-19 vaccine before Christmas
Updated On : 17 Nov 2020 | 12:43 AM IST

Moderna, Pfizer Covid-19 vaccines look strong: Here's how they stack up

The data will likely increase confidence that more vaccines will work and that the world may soon find a way to get the coronavirus under control

Moderna, Pfizer Covid-19 vaccines look strong: Here's how they stack up
Updated On : 16 Nov 2020 | 7:39 PM IST

Moderna Covid-19 vaccine stability could give it edge over Pfizer's version

The vaccine is more stable than expected at temperatures that ordinary refrigerators can provide

Moderna Covid-19 vaccine stability could give it edge over Pfizer's version
Updated On : 16 Nov 2020 | 6:19 PM IST

Diwali brings hopes for economic revival

The spread of Covid-19 has been contained in most parts of our country

Diwali brings hopes for economic revival
Updated On : 16 Nov 2020 | 12:57 AM IST

Covid-19 crisis: Normal life back likely next winter, says BioNTech CEO

BioNTech co-founder Uğur Şahin told BBC One's The Andrew Marr Show on Sunday: "this winter will be hard and the vaccine will not have a big impact on the infection numbers

Covid-19 crisis: Normal life back likely next winter, says BioNTech CEO
Updated On : 16 Nov 2020 | 12:39 AM IST